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Abstract
Transcriptome analysis by total mRNA proling provides a measurement
of the degree of variation for the amount of each single mRNA species after
a physiological or pathological transition of cell state. It has become a gen-
eral notion that variations in protein levels do not necessarily correlate with
variations in total mRNA levels, for the presence of post-transcriptional
controls which inuence the fate of cytoplasmic mRNAs and aect their
translational tness. Nevertheless, the extent of this phenomenon and the
rules, if any, governing it are still generally unknown. To address this
issue we took advantage of a number of studies performed using polyso-
mal mRNA proling in combination with classical total mRNA proling
in dierent mammalian and yeast systems. A normalization of the raw
data coming from these datasets and a statistical meta-analysis aimed at
maximizing uniformity in data processing have been performed. From the
comparison of the results an extensive uncoupling between transcriptome
and translatome variations of mRNA levels emerges, measured by a sig-
nicant dierence between steady state and polysomal fold changes induced
by a cellular physiological or pathological transition. It seems clear that
virtually the majority of signicant changes in cytoplasmic mRNA steady-
state levels are subjected to a further elaboration by a post-transcriptional
decision program, leading either to a widespread buering of the cytoplas-
mic changes which transfers only a small fraction of them to translation,
either to the creation of new changes which cannot be detected at the tran-
scriptional level, yet capable of heavily inuencing protein synthesis rates.
An explanatory model characterized by a cytoplasmic mRNA storage com-
partments is proposed and the involvement of P-bodies and the miRNA
pathway in post-transcriptional reprogramming of gene expression has been
experimentally tested in the biological model of EGF induction, in order
to explain how a change in translational tness can counteract or mag-
nify a parallel change in citoplasmic mRNA availability. To investigate
the role of specic cellular mechanism in generating uncoupling between
transcriptome and translatome changes, the experimental model has been
altered through silencing of three key genes involved in post-transcriptional
regulation pathways: 4E-T, Xrn1 and Dicer.
Keywords
[Translational controls, post-transcriptional regulation, polysomal prol-
ing, microarray analysis, ]
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Chapter 1
Introduction
The central dogma of molecular biology states that genetic information
ows from nucleic acids to proteins [1]. In order to survive, living organisms
have to regulate the expression of thousands of genes in response to mul-
tiple cellular needs and environmental stimuli. Expression control systems
have to respond quickly and precisely to specic signals, and tune the level
of expression of genes to regulate cell growth, adaptation to stress, home-
ostasis, and dierentiation. In the past years scientic research on gene
expression was mainly oriented towards decoding the molecular mecha-
nisms of transcriptional control. This bias has both historical and technical
reasons, since transcriptional control is the most basic step of gene expres-
sion and is simple to study with well-established experimental methods,
but now the paradigm has changed and post-transcriptional regulations
of mRNAs, including pre-mRNA splicing, maturation and quality control,
mRNA transport to the cytoplasm [2] [3], localization in space and time
[4] [5], editing [6], stability and degradation [7] [8], silencing and interfer-
ence [9], circularization [10], translation initiation [11], nonsense-mediated
mRNA decay [12]. All these processes acting on mRNA molecules are in-
creasingly recognized as fundamental and inuential steps in the ow of
genetic information. Post-transcriptional regulation is dependent on the
1
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activity of trans-acting factors, mainly RNA binding proteins (RBPs) [13],
and non coding RNAs (ncRNAs) [14] which bind to cis consensus elements
present mainly in the 3' and 5' untranslated regions of mRNAs, as pre-
sented schematically in gure 1.1
Figure 1.1: Linear structure of an eukaryotic mRNA, showing untrans-
lated regions at both ends, with the main trans-acting factors (RNA
binding proteins interacting mainly with 5'UTR and 3'UTR, microR-
NAs interacting mainly with 3'UTRs) involved in post-transcriptional
controls of gene expression.
The polysome proling technique involves separation of mRNA/ribosomal
complexes by sucrose gradient centrifugation into ineciently translated
fractions (corresponding to monosomes or free mRNPs) and eciently
translated fractions (corresponding to polysomes) [15]. Microarray tech-
nology is then used to quantify the levels specic transcripts and detect
which ones are redistributed between the dierent fractions in response
to some stimulation, allowing recognition of translational up- or down-
regulation at a gene-specic level. DNA microarray analysis can be used
to simultaneously monitor transcriptome and translational changes in a
cell. The analysis of a transcriptome through total RNA proling pro-
vides only information on the template that is available for a cell to un-
dergo translation processes under certain physiological conditions. Any-
way, proteins are the real eectors of cell phenotype, and their levels and
activities do not necessarily correlate with total mRNA levels, because
2
post-transcriptional controls act in the middle. In fact, the synthesis of
individual protein species is regulated not only by transcript level, but by
cis and trans elements that confer unique translational properties (a spe-
cic translational tness) on individual mRNA molecules, and determine
their fate: translation, degradation or silencing. The progressive discovery
of how much post-transcriptional controls are pervasive and weighty has
led to the conclusion that the explicit analysis of these mechanisms is de-
terminant and unavoidable if we want to study biological systems without
incurring in deviant simplications [16]. Several works in the past ten years
have compared transcriptome mRNA levels to the corresponding protein
levels using high-throughput techniques, and they all have shown that the
correlation level between the two measures is globally limited. It seems
that the dierential expression of mRNAs (in both directions, up or down)
can capture and predict at most 60% of the corresponding variations of
protein expression [17] [18]. This result is indeed limited to the number
of proteins for which a direct comparison between high-throughput tran-
scriptomic and proteomic measures are available. In light of these points, it
would be valuable to have information on mRNA expression patterns with
estimates of translation eciencies of individual transcripts. Polysomal
mRNA proling should be more informative in this direction, revealing
every mRNA whose translation is uncoupled from its transcription. In
the last few years several works have been published in many scientic
journals on the comparison between total mRNA proling, based on the
extraction and microarray analysis of all the mRNA contained in the stud-
ied cells, and polysomal proling, based on the extraction and analysis of
polysomal mRNA, i.e. the fraction of mRNA which is actively translated
at the moment of the extraction. For the analysis presented in chapter
3 all the works whose raw data were at disposal have been considered.
Dierent datasets have been classied according to the dierent phenom-
3
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ena which are expected to generate a phenotypic variation in the studied
cells. Most of these works compare total RNA data with polysomal RNA
data, a minority of them compare polysomal RNA data with subpolysomal
RNA data, derived from the analysis of poorly translated RNA fractions
on the sucrose gradient. Post-transcriptional regulation of gene expression
is much more intricate than previously thought, and elucidating the basic
mechanisms of post-transcriptional control will be essential to gain a full
understanding of how gene expression is regulated at dierent levels, of the
interplay between these mechanisms, and of the extensive involvement of
post-transcriptional dysfunction in numerous genetic disorders and cancer.
1.1 Proposed Solution
Expression levels for total and polysomal RNAs were calculated from raw
data and normalized using the Robust Multichip Average algorithm (RMA)
implemented in the Ay package of Bioconductor [19]. Signicant dier-
entially expressed genes in the total and polysomal RNA fractions were
identied using a statistical technique based on rank products and im-
plemented in the RankProd package of Bioconductor [20]. In comparison
with other techniques for detection of dierentially expressed genes, this
one has been proven to be particularly suited to meta-analysis of multi-
ple microarray experiments based on dierent platforms [21]. Populations
of dierentially expressed genes detected from transcriptome proling and
translatome proling were compared and overlapped in order to calculate
a categorical measure of uncoupling based on gene identities.
In order to model uncoupling as a quantitative measure, principal com-
ponent analysis was performed on total RNA and polysomal RNA fold
changes values: the underlying assumption is that the rst principal com-
ponent pins down the ideal line on which polysomal and total fold changes
4
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Figure 1.2: Diagram showing how external and internal perturbations
reprogram gene expression regulation at a double level, transcriptional
and translational, originating three types of dierentially expressed
genes (DEGs): those detectable only by transcriptome proling, those
detectable only by translatome proling, those detected by both anal-
yses.
are perfectly related. Uncoupling between transcriptome and translatome
changes can be measured for all genes as their distance from the rst prin-
5
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cipal component. Since the collected datasets originated from dierent
species, orthologous gene families among Homo sapiens, Mus musculus
and Rattus norvegicus have been created using ENSEMBL orthology rela-
tions, in order to assess the recurrent presence of homologous genes in the
populations of coupled or uncoupled genes.
1.2 Innovative Aspects
Computational meta-analysis: Comprehensive analysis of all published
and high-quality microarray comparisons between transcriptome and
translatome proling data. Calculation of categorical uncoupling as
the overlapping degree between lists of transcriptome and translatome
dierentially expressed genes. Calculation of quantitative uncoupling
applying principal component analysis to transcriptome and trans-
latome fold changes and considering the second principal component
as the uncoupling dimension. Calculation of an ontological uncou-
pling, which measures the amount of alternative biological conclusions
which can be drawn from the ontological analysis of these lists.
Experimental validation and alteration of uncoupling: Validation of
uncoupling in a model of EGF induction and alteration of the model
through silencing of key genes involved in post-transcriptional regula-
tion pathways: 4E-T, Xrn1, Dicer.
Bayesian inference: Use of a bayesian inference approach to predict re-
lationships between RNA binding proteins and target mRNAs based
on changes in their translation eciencies. Implementation and suc-
cessful testing with synthetic data.
Untranslated sequences analysis: identication of hyper-conserved se-
quences in 5'UTR and 3'UTR of vertebrates, based on both sequence
6
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identity and evolutionary coverage.
Ontology: Conceptualization of the "post-transcriptional regulation of
gene expression" domain through design and implementation in OWL
of the USER ontology.
Evolutionary approach: Sequence similarity based identication of a
superfamily of RNA binding proteins with multiple RRM domains
evolving from the PABP family and dierentiating in binding speci-
cities and performed molecular tasks.
1.3 Structure of the Thesis
Chapter 1: Introduction where the biological context, post-transcriptional
regulation of gene expression, is briey presented. The problem, lack
of bioinformatic resources and information targeted to the discovery
of post-transcriptional networks, is introduced. The solution proposed
by this thesis and its innovative aspects are also outlined.
Chapter 2: State of the Art Where the biological information about
post-transcriptional regulation and the currently available bioinfor-
matic resources are described.
Chapter 3: Metanalysis results where transcriptome and translatome
proling data collected from literature are analyzed following the same
pipeline, leading to a categorical and a quantitative measure of un-
coupling.
Chapter 4: Experimental validation where uncoupling is veried in
an experimental model of EGF induction in HeLa cells. The biologi-
cal model is then altered through silencing of post-transcriptional key
genes, in order to assess the involvement of p-bodies and the miRNA
7
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pathway in the post-transcriptional reprogramming of gene expres-
sion.
Chapter 5: Conclusions where the results are summarized and future
perspectives are outlined
Appendix A: Bayesian inference: where a bayesian inference model is
designed to infer relationships between RNA binding proteins and
mRNAs from translatome proling experiments.
Appendix B: Ontology: where the USER ontology (Untranslated Se-
quence Elements for Regulation) is described.
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Chapter 2
State of the Art
2.1 Gene expression
Gene expression is the process by which genome sequence is turned into
proteins enabling our life. This process is divided into two main steps:
transcription and translation. Transcription, also called RNA synthesis, is
the step by which portions of DNA sequence are copied into molecules of
messenger-RNA(mRNA). RNA polymerase and transcription factors are
the main actors leading this process. The second step, translation, occurs
on ribosomes, macromolecular complexes composed by proteins and RNA.
At that moment, the mRNA sequence is read by the ribosome, codon by
codon, in order to produce polypeptide chains. When translation is com-
pleted, the mature protein is released by the ribosome. Each mRNA in-
cludes two noncoding regions, called 5' and 3' UTR (Untranslated Region)
at the beginning and at the end of the transcribed sequence. Transla-
tion of mRNAs is regulated also by means of these regions, thus making
them particularly important. These regions both contain regulatory se-
quences, making them cis-regulatory elements(they contain sequences reg-
ulating the expression of the gene on the same strand), and are target of
trans-factors(proteins used in the regulation of another target gene) like
RNA-binding proteins.
9
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2.1.1 mRNA maturation
Next to transcription, some further processing allows eukaryotic cells to
produce mature and functional mRNAs from the newly transcribed RNA
molecules(called pre-mRNA). First of all, the 5' cap is added at the begin-
ning of the transcript to avoid premature degradation during export from
the nucleus to the cytoplasm. A similar process, driven by poly(A) poly-
merases and helped by PABPs(Poly-A Binding Proteins), adds a string
of 100-250 adenine residues to the 3' end of the transcript; this struc-
ture, called 3' poly(A)-tail, avoids the premature degradation of the tran-
script. Next, the splicing process deletes non coding-regions, called in-
trons, from the RNA and joins the remaining regions, called exons, into
a single sequence. An important process, called alternative splicing, al-
lows to produce dierent mature mRNA transcripts by selecting dierent
combinations of exons from the same pre-mRNA. Dierent proteins can
be produced in this way from a single gene. Once all these processes are
terminated, the structure of the produced functional mRNA, as illustrated
in gure 1.1 starts with the 5' cap at the beginning of the transcript; then
comes the 5'UTR, the coding sequence, and the 3'UTR; the mRNA is even-
tually closed by the 3' poly(A)-tail. Usually, the 3' UTR is much longer
then the 5' UTR; the mean length of human UTRs is around 500 bases for
3' and 150 for 5'.
2.1.2 RNA export to the cytoplasm
In eukaryotes, translation of mRNA into functional proteins takes place in
the cytoplasm, while transcription is a nuclear process. There is thus the
need of transporting the mature mRNA outside of the nucleus to allow its
translation: this can be done via structures nuclear pores that, localized
on the nucleus membrane allow the export of RNA molecules. Nuclear
10
2.1. GENE EXPRESSION
pores are composed by more than 100 proteins called nucleoporines, act-
ing as selective pores allowing or prohibiting molecules passage. Diverse
RNA-binding proteins(RBP) binds to the mRNA forming the mRNP com-
plex; transport of this complex is further facilitated by mRNA-export units
which interacts with specic proteins to allow transfer of the molecule to
the cytoplasm. During this process, the mature mRNA is protected both
by its cap and by the bound RBPs [2].
Figure 2.1: Figure taken from [2] showing the dierent RNA export
routes for several RNA classes.
2.1.3 mRNA stability regulation
One important level of post-transcriptional regulation involves mRNA sta-
bility: proteins binding to control elements usually located in the 3'UTR
can alter the decay rate of a transcript, thus favoring its quick degradation
or slowing it down [8]. Elements in the 3'UTR that were observed to be
associated with high decay rates are the AU-rich elements (AREs), which
are regions composed by a great majority of A and U [22]; an example of
trans-acting factor is the PUF (Pumilo and feminizing mutation-3 mRNA-
11
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binding factor) RNA-binding protein family, which binds to the 3'UTR
of the target transcripts and shorten their poly(A)-tail, thus reducing the
stability of the mRNA. Shortening of the poly(A)-tail is indeed a very com-
mon way of targeting mRNAs for degradation: once the tail is too short
for PABP binding, even the stabilization of 5' cap and initiation factors
can no longer occur, thus favoring 5' decapping and consequent mRNA
degradation by exonucleases.
Exosomes are important actors in mRNA degradation, being multi-
protein complexes capable of degrading various kinds of RNA molecules.
Instead of cleaving RNA molecules at a specic site, this complexes degrade
RNA molecules by starting at the 3' end. Regulated at their turn by dier-
ent proteins, exosomes are known to be involved in autoimmune diseases
and cancer onset. Messenger RNAs are targeted to these complexes when
they contain errors or as a part of their normal turnover; exosomes can also
interact with RNA binding proteins interacting with AU-rich elements.
2.1.4 Transport between cytoplasmic granules
Polysomal RNA assumes a circularized conformation through interactions
between poly(A)-binding protein 1 (PABP1) on 3'UTR and eukaryotic
translation initiation factor 4G (eIF4G) on 5'UTR, which are stabilized
by eIF3. In eukaryotic cells circularization is a necessary step bringing
to the formetion of polyribosomes or polysomes: complexes of more ribo-
somes attached to the same mRNA molecule.Transformation of polysomes
into linearized messenger ribonucleoproteins (mRNPs) seem to involve the
transport to p-bodies, whereas circularized mRNPs are directed to stress
granules. In the p-bodies pathway, the deadenylation complex CCR4NOT1
is recruited by destabilizing factors, such as tristetraprolin (TTP), or RNA-
induced silencing complexes (RISCs), involving Argonaute proteins and mi-
croRNAs. Loss of circularization by loss of eIF3 or deadenylation-induced
12
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loss of PABP1 produces a linear transcript. This linear mRNA recruits a
decapping complex (which consists of decapping protein 1 (DCP1; DCP1A
in humans), DCP2, enhancer of mRNA-decapping protein 3 (EDC3), RCK
(also known as DDX6) and HEDLS) and a decapping activator complex
(PAT1 bound to LSM17; PAT1 is not shown). Q/N-rich domains in LSM4
and EDC3 promote the aggregation of these mRNAs into PBs. In the
'circular' pathway (right), transiently stalled initiation complexes recruit
TIA1 and TIAR (together shown as TIA) as elongating ribosomes run o
the transcript, converting the polysome into a circular, adenylated mRNP.
Aggregation of bound TIA1 and TIAR or G3BPUSP10 (G3BP is GTPase-
activating protein SH3 domain-binding protein and USP10 is ubiquitin-
specic processing protease 10) and/or modication of ribosomes with O-
linked N-acetylglucosamine (GlcNAc) promote the assembly of these mR-
NAs into SGs. It is possible that mRNPs in PBs or SGs can be remodelled
to nucleate the assembly of other types of RNA granules. Alternatively,
selected mRNPs might move from one type of granule to another, thus
creating transient tethers between dierent granules.[23]
2.1.5 Cap-dependent translation initiation
Translation initiation is the process of assembly of 80S ribosomes where the
initiation codon is base-paired with the anticodon loop of initiator tRNA in
the ribosomal P-site. It requires at least nine eukaryotic initiation factors
(eIFs) and comprises two steps: the formation of 48S initiation complexes
with established codonanticodon base-pairing in the P-site of the 40S ribo-
somal subunits, and the joining of 48S complexes with 60S subunits. On
most mRNAs, 48S complexes form by a scanning mechanism, whereby
a 43S preinitiation complex (comprising a 40S subunit, the eIF2GTPMet-
tRNAMet ternary complex, eIF1, eIF1A and probably eIF5) attaches to the
capped 5' proximal region of mRNAs in a step that involves the unwinding
13
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Figure 2.2: Taken from [23]. Molecular pathways connecting actively
translating polysomes to distinct cytoplasmic storage and degradation
granules: p-bodies and stress granules.
of the mRNAs 5' terminal secondary structure by eIF4A, eIF4B and eIF4F.
The 43S complex then scans the 5' untranslated region (5' UTR) in the 5' to
3' direction to the initiation codon. After initiation codon recognition and
48S complex formation, eIF5 and eIF5B promote the hydrolysis of eIF2-
bound GTP, the displacement of eIFs and the joining of a 60S subunit.
Although most mRNAs use the scanning mechanism, initiation on a few
mRNAs is mediated by internal ribosome entry sites.
Cap-dependent translation initiation entails the recruitment of the 40S
14
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small ribosomal subunits (and associated factors) to the 5' end of the mR-
NAs. In this process, the mRNA 5'-cap structure, m7GpppN (where N
is any nucleotide), is recognized by eukaryotic initiation factor (eIF) 4E,
one of the subunits of the eIF4F complex. The eIF4F complex also con-
tains eIF4A, an ATP-dependent RNA helicase which is thought to unwind
secondary structure present at the 5' end of the mRNA, and eIF4G, a
large scaolding protein that binds to eIF4E, eIF4A, PABP, and eIF3,
consequently bridging the ribosome and the mRNA. eIF4E is the limit-
ing factor in translation initiation under most circumstances and is an
important eector of cellular proliferation, survival, and malignant trans-
formation. The activity of eIF4E is regulated by a family of translational
suppressors called the 4E-binding proteins (4E-BPs), which in mammals
consists of three members: 4E-BP1, 4E-BP2, and 4E-BP3. 4E-BP1 and
4E-BP2 are expressed in most tissues, whereas 4E-BP3 exhibits a more
restricted expression pattern. Binding of the 4E-BPs to eIF4E is con-
trolled by the phosphorylation status of 4E-BPs. The hypophosphory-
lated forms of 4E-BP bind to eIF4E and prevent interaction of eIF4E with
eIF4G, thus impairing cap-dependent translation. Conversely, in nutrient-
or serum-stimulated cells, 4E-BPs become hyperphosphorylated, releasing
eIF4E for interaction with eIF4G and assembly into the eIF4F complex,
resulting in enhanced translation. The best-characterized 4E-BP is 4E-
BP1, which contains six known proline-directed Ser/Thr phosphorylation
sites, among which at least two sites are phosphorylated directly by mTOR
(mammalian target of rapamycin). mTOR is a phylogenetically conserved
Ser/Thr kinase that regulates cell growth and metabolism in response to
diverse extracellular and intracellular cues. Growth factors and hormones
(insulin/IGF), nutrients (amino acids/glucose), and high ATP/AMP ra-
tio activate mTOR, resulting in hyperphosphorylation of 4E-BP1. Ra-
pamycin, an inhibitor of mTOR, impairs the phosphorylation of 4E-BP1.
15
CHAPTER 2. STATE OF THE ART
While eIF4E is predominantly cytoplasmic, in mammalian cells and in
yeast, a signicant fraction (12% 33% in mammalian) is localized to the
nucleus at steady-state levels as determined by biochemical fractionation
studies and immunouorescence analysis using several antibodies. In the
nucleus, eIF4E colocalizes with splicing factors in speckles. The nuclear
import of eIF4E is mediated by 4E-T (eIF4E-transporter), which binds to
eIF4E through a conserved binding motif shared with 4E-BPs and eIF4G,
and simultaneously interacts with nuclear import receptors, importin  
(Dostie et al. 2000a). While the role of eIF4E in the nucleus has not been
as extensively studied as its cytoplasmic role, it is known to promote the
nuclear export of a subset of mRNAs. How the steady-state pool of nuclear
eIF4E is maintained and regulated is not clear.
2.2 Bioinformatic coverage of post-transcriptional con-
trols
Actually there are many bioinformatic resources which cover particular
facets of the post-transcriptional regulation eld. Many of the available
databases are manually curated by few people belonging to single labora-
tories: this can lead to several negative consequences:
 when curators move to other research groups or to other projects, they
usually are not replaced and the databases, without the necessary
updates, freeze and lose their usefulness
 databases are partially redundant in the data they display
 databases are isolated, since they may provide web links to each other
but they lack integration at the data level
These are common problems in biological databases, partially due to the
dicult task of organizing and collecting data which evolve rapidly follow-
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ing changes in the experimental procedures and in the knowledge repre-
sentations shared by the scientic community: this informational turnover
is particularly marked in the dynamic and emerging post-transcriptional
control eld. The bioinformatic long term aim of the Laboratory of Trans-
lational Genomics at CiBio is to equip this fragmented and volcanic domain
of poleis-like databases with a common platform through which the user
could get a unied and meaningful view of post-transcriptional processes
and make quantitative predictions on their combined eect on mRNA con-
trol and fate.
2.3 Proteome-Transcriptome comparisons
Several works in the past ten years have compared transcriptome mRNA
levels to the corresponding protein levels using high-throughput techniques,
and they all have shown that the correlation level between the two mea-
sures is globally limited. It seems that the dierential expression of mRNAs
(in both directions, up or down) can capture and predict at most 60% of
the corresponding variations of protein expression [17] [18]. This result
is indeed limited to the number of proteins for which a direct compari-
son between high-throughput transcriptomic and proteomic measures are
available.
17
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Figure 2.3: Picture taken from [11] showing the sequence of steps in-
volved in the canonical pathway of cap-dependent translation initiation.
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Figure 2.4: Multiple steps of regulation from transcription to transla-
tion occurring in eukaryotic cells and involving the binding of RBPs
and small non-coding RNAs to cis-acting motifs on mRNAs. Adapted
from [24].
Figure 2.5: Comparison of mRNA expression and protein abundance
taken from [18]. The mRNA axis is in copies per cell; the protein axis
is in thousand copies per cell.
19
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Figure 2.6: Scatter plot of mRNA versus cognate protein fold changes
taken from [17]. The overall correlation coecient for all the 425 genes
in the analysis is 0.59.
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Computational detection of
uncoupling: metanalysis
Genome-wide measurements of mRNA variations are widely proposed as
truthful representations of changes in global protein abundance system-
atically neglecting the impact of post-transcriptional events. To estimate
this impact we performed a normalized analysis of all technically compara-
ble mammalian datasets for which coupled transcriptome and translatome
[25] (mRNA extracted from cytoplasmic polysomal fractions) microarray
proles were available. We found that a general, profound uncoupling be-
tween transcriptome and translatome gene espression variations emerges
as a rule. Moving to ontological analysis of dierentially expressed genes,
an approach based on semantic similarity between Gene Ontology terms
has shown that only in the minority of the datasets the semantic dis-
tance between transcriptome and translatome representations of each of
the compared datasets outlies the distribution of the same measure com-
puted between disparate pairwise transcriptome representations. These
results severely question the information completenesss of transcriptome
proles in directly representing cell phenotypes and in portraying cell ac-
tivities.
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3.1 Identication of DEGs
Datasets containing comparisons between polysomal and total RNA levels
have been collected through extensive researches in literature and in the
main microarray databases: GEO 1, ArrayExpress 2, Stanford Microarray
Database 3. Datasets without complete available raw data or without hy-
bridization replicas for every experimental condition were excluded from
the meta-analysis. The selected datasets are listed and described in Table
3.1. Though original data were organized in dierent experimental designs,
in each one a two-group comparison (treated group vs. control group)
between total and polysomal RNA levels was possible. Microarray data
were analyzed using the R software environment for statistical computing
(http://www.r-project.org/) and the Bioconductor library of biostatisti-
cal packages (http://www.bioconductor.org/). The expression levels for
all arrays were calculated from raw data with the RMA (Robust Multi-
chip Average) algorithm implemented in the Ay package of Bioconductor
(http://www.bioconductor.org/packages/release/bioc/html/ay.html). Par-
allel normalization was carried out for total and polysomal RNA hybridiza-
tions. Probesets were associated to their corresponding Ensembl gene IDs.
Ambiguous probesets, i.e. probesets associated to more than one Ensembl
gene ID because of annotation imperfections or annotation changes in time,
were ltered out from the analysis at this stage. Signals from multiple
probesets associated to the same gene were averaged. To identify dier-
entially expressed genes (DEGs) in either the total or the polysomal frac-
tions, three dierent statistical approaches were addressed: Rank Prod-
uct, SAM (Signicance Analysis of Microarrays) and t-test. The Rank
Product algorithm, implemented in the Bioconductor RankProd package
1http://www.ncbi.nlm.nih.gov/geo
2http://www.ebi.ac.uk/microarray-as/ae/
3http://smd.stanford.edu/
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(http://www.bioconductor.org/packages/release/bioc/html/RankProd.html),
uses a technique based on calculating rank products from replicate exper-
iments. A permutation-based procedure is used to determine false discov-
ery rate values, estimated by RankProd as "Percentages of False Positives"
(pfp). A threshold of 0.2 on the pfp value was used to lter DEGs in either
the total RNA or the polysomal RNA comparison.
DEGs were identied as belonging to transcriptomic or translatomic
hybridizations.
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+EPO.0−2h
−LIF.0−5d
+LPS.0−1h
+LPS.0−2h
+LPS.0−4h
+CD95L.0−48h
+LPS.DC.0−4h
+LPS.DC.4−46h
+LPS.DC.0−16h
+diff.WT.hepa
+diff.mTOR.hepa
+diff.testis.P17−P22
+diff.testis.P17−P70
+diff.testis.P22−P70
+diff.lung.E19−E22
+diff.lung.E19−P1
+diff.lung.E22−P1
+eIF4E
−eIF4GI
+v−Ki−ras
+mTOR.no−diff
+mTOR.diff
+muscle.contr.0−6h
+carc.progr.
Percentage of genes
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Figure 3.1: DEGs overlap between transcriptome and translatome lev-
els. Each dataset in the bar graph is displayed to the left of its descrip-
tion in A. Genes are classied as DEGs by both transcriptome and
translatome prolings (green), as DEGs only by transcriptome pro-
ing (blue) or as DEGs only by translatome proing (yellow). The bar
length shows the relative proportion of DEGs in these three groups for
each dataset.
23
CHAPTER 3. COMPUTATIONAL DETECTION OF UNCOUPLING:
METANALYSIS
Short ID Species Source Description Ref.
+serum.0-2h Mm MEFs serum starvation release [26]
+EPO.0-2h Mm I/11-R10 EPCs erythroid EPO deprivation release [27]
-LIF.0-5d Mm embrionic stem
cells R1
stem cell dierentiation through
LIF removal
[28]
+LPS.0-1h Mm J774.1 macrophage LPS treatment [29]
+LPS.0-2h Mm J774.1 macrophage LPS treatment [29]
+LPS.0-4h Mm J774.1 macrophage LPS treatment [29]
+CD95L.0-48h Mm neural stem cells CD95L treatment [30]
+LPS.DC.0-4h Hs dendritic cells dendritic cell LPS treatment [31]
+LPS.DC.4-46h Hs dendritic cells dendritic cell LPS treatment [31]
+LPS.DC.0-16h Hs dendritic cells dendritic cell LPS treatment [31]
+di.WT.hepa Hs HepaRG dierentiation of WT hepatocytes [32]
+di.mTOR.hepa Hs HepaRG dierentiation of mTOR activated
hepatocytes
[33]
+di.testis.P17-P22 Mm testis tissue testis dierentiation [34]
+di.testis.P17-P70 Mm testis tissue testis dierentiation [34]
+di.testis.P22-P70 Mm testis tissue testis dierentiation [34]
+di.lung.E19-E22 Rn lung tissue lung dierentiation [?]
+di.lung.E19-P1 Rn lung tissue lung dierentiation [?]
+di.lung.E22-P1 Rn lung tissue lung dierentiation [?]
+eIF4E Hs primary MECs eIF4E overexpression [35]
-eIF4GI Hs MCF10A eIF4GI depletion
+v-Ki-Ras Hs 267B1/267B1-
Ki-ras
v-Ki-ras transformation [36]
+mTOR.no-di Hs HepaRG mTOR activation of proliferative
hepatocytes
[33]
+mTOR.di Hs HepaRG mTOR activation of dierentiated
hepatocytes
[33]
+muscle.contr.0-6h Rn skeletal my-
ocites
muscle subjected to high resistance
contractions
[37]
+carc.progr. Hs SW480/SW620 carcinoma progression from pri-
mary cells to metastatic cells
[38]
Table 3.1: Datasets collection and classication on the basis of experimental
perturbations applied. The red cluster indicates extracellular signaling events, the
blue cluster is related to tissue dierentiation, the green concerns genetic alterations
of the translational machinery. Datasets are labelled by short names specifying
perturbations and time points. Short names and color codes are used throughout the
text to indicate the datasets belonging to each cluster. Species, biological sources,
experimental settings and bibliographical references are summarized as well.
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DEGs numbers
Short ID only tot only poly common
+serum.0-2h 61 74 32
+EPO.0-2h 20 132 413
-LIF.0-5d 715 662 959
+LPS.0-1h 587 535 308
+LPS.0-2h 970 610 364
+LPS.0-4h 785 1063 628
+CD95L.0-48h 63 7 72
+LPS.DC.0-4h 477 1914 364
+LPS.DC.4-46h 761 1608 208
+LPS.DC.0-16h 805 2106 317
+di.WT.hepa 513 138 93
+di.mTOR.hepa 707 258 180
+di.testis.P17-P22 523 721 106
+di.testis.P17-P70 429 870 216
+di.testis.P22-P70 339 478 92
+di.lung.E19-E22 317 810 298
+di.lung.E19-P1 461 998 464
+di.lung.E22-P1 131 351 369
+eIF4E 178 132 452
-eIF4GI 626 168 467
+v-Ki-ras 276 212 49
+mTOR.no-di 217 58 22
+mTOR.di 138 41 17
+muscle.contr.0-6h 129 61 132
+carc.progr. 558 502 999
Table 3.2: Description of the parameters calculated from simulation 1
3.2 Ontological uncoupling
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Figure 3.2: Semantic similarity between total and polysomal terms in-
side the same dataset is compared with the distribution of semantic sim-
ilarities coming from pairwise comparisons between dierent datasets.
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GO terms statistics
Short ID only tot only poly common gain loss jaccard
+serum.0-2h 29 35 22 0.31 0.17 0.52
+EPO.0-2h 13 77 13 0.83 0 0.17
-LIF.0-5d 70 159 62 0.58 0.05 0.37
+LPS.0-1h 119 84 82 0.02 0.31 0.68
+LPS.0-2h 172 101 93 0.04 0.44 0.52
+LPS.0-4h 203 133 115 0.08 0.40 0.52
+CD95L.0-48h 0 0 0 0 0 0
+LPS.DC.0-4h 160 144 125 0.11 0.20 0.70
+LPS.DC.4-46h 93 98 65 0.26 0.22 0.52
+LPS.DC.0-16h 189 177 139 0.17 0.22 0.61
+di.WT.hepa 140 13 9 0.03 0.91 0.06
+di.mTOR.hepa 151 19 19 0 0.87 0.13
+di.testis.P17-P22 95 70 60 0.10 0.33 0.57
+di.testis.P17-P70 114 70 56 0.11 0.45 0.44
+di.testis.P22-P70 63 34 31 0.04 0.48 0.47
+di.lung.E19-E22 146 109 88 0.13 0.35 0.53
+di.lung.E19-P1 158 117 104 0.08 0.32 0.61
+di.lung.E22-P1 74 38 34 0.05 0.51 0.44
+eIF4E 29 18 8 0.26 0.54 0.20
-eIF4GI 81 51 23 0.26 0.53 0.21
+v-Ki-ras 89 43 40 0.03 0.53 0.43
+mTOR.no-di 13 2 2 0 0.85 0.15
+mTOR.di 7 0 0 0 1 0
+muscle.contr.0-6h 30 41 14 0.47 0.28 0.25
+carc.progr. 74 111 57 0.42 0.13 0.44
Table 3.3: Number of signicantly enriched GO terms found analyzing lists of
DEGs coming from total and polysomal proling
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KEGG-INTERPRO-PIR terms statistics
Short ID only tot only poly common gain loss jaccard
+serum.0-2h 3 7 2 0.62 0.12 0.25
+EPO.0-2h 2 18 2 0.89 0 0.11
-LIF.0-5d 10 19 6 0.56 0.17 0.26
+LPS.0-1h 50 41 34 0.12 0.28 0.60
+LPS.0-2h 45 25 22 0.06 0.48 0.46
+LPS.0-4h 53 44 32 0.18 0.32 0.49
+CD95L.0-48h 0 0 0 0 0 0
+LPS.DC.0-4h 40 32 26 0.13 0.30 0.56
+LPS.DC.4-46h 17 26 14 0.41 0.10 0.48
+LPS.DC.0-16h 48 48 37 0.19 0.19 0.63
+di.WT.hepa 54 6 4 0.04 0.89 0.07
+di.mTOR.hepa 68 18 18 0 0.73 0.26
+di.testis.P17-P22 17 11 7 0.19 0.48 0.33
+di.testis.P17-P70 25 11 6 0.17 0.63 0.20
+di.testis.P22-P70 10 6 6 0 0.40 0.60
+di.lung.E19-E22 11 8 5 0.21 0.43 0.36
+di.lung.E19-P1 6 5 3 0.25 0.38 0.38
+di.lung.E22-P1 1 1 0 0.50 0.50 0
+eIF4E 12 10 5 0.29 0.41 0.29
-eIF4GI 18 13 4 0.33 0.52 0.15
+v-Ki-ras 46 13 12 0.02 0.72 0.26
+mTOR.no-di 20 6 5 0.05 0.71 0.24
+mTOR.di 20 0 0 0 1 0
+muscle.contr.0-6h 0 2 0 1 0 0
+carc.progr. 16 30 9 0.57 0.19 0.24
Table 3.4: Number of signicantly enriched KEGG terms found analyzing lists of
DEGs coming from total and polysomal proling. The number of DEGs found only
with transcriptome analysis, only with translatome analysis and in both analyses
are visualized.
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Experimental validation of
uncoupling
As we said before, translatome analysis by sucrose gradient centrifuga-
tion of cell lysates followed by microarray proling of the polysomal and
subpolysomal RNA fractions represents a way of both studying transla-
tional control networks and better approximating the proteomic represen-
tation of cells. It is an established notion that translational control takes
place essentially at the translation initiation level, therefore the variation in
abundance of a given mRNA species on polysomes can be directly related
to the variation in abundance of the corresponding protein. Comparison
of translatome prole changes with corresponding transcriptome prole
changes can provide a measure of the degree of concordance between cel-
lular controls aecting mRNA abundance and cellular controls aecting
mRNA availability to translation. To provide a direct experimental evalu-
ation of the phenomenon, we decided to study a classical example of tran-
scriptional reprogramming of gene expression: Epidermal Growth Factor
(EGF) treatment. This stimulus triggers a well known chain of intracellu-
lar transduction events, ultimately resulting in a multifaceted phenotypic
spectrum of changes with prevalent induction of cell growth and prolifer-
ation. We subjected HeLa cells to serum starvation for 12h and then we
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added EGF at nal concentration of 1 microgram/ml, proling before and
after 40 minutes of treatment the transcriptome, the translatome, com-
ing from the polysomal pool of mRNAs after sucrose gradient separation,
and also the mRNA content of the subpolysomal pool, expected not to be
actively translated.
Aim of the chapter. The aim of this experiment is to verify the
results obtained by the bioinformatic analysis described in chapter 3, ex-
perimentally validating the existence of uncoupling between transcriptome
and translatome variations as a general cellular process, and identifying
which mechanisms and regulatory circuits are mostly responsible for the
reprogramming of gene expression at the translational level.
Materials and methods. To conrm the uncoupling between tran-
scriptome and translatome, proliferative induction triggered by Epidermal
Growth Factor (EGF) after serum starvation in HeLa cells has been chosen
as biological model. The alteration of this model has been performed by
RNA interference, silencing 3 genes deeply involved in post-transcriptional
control (4E-T, XRN1 e Dicer). After evaluating the degree of silencing
at the protein level by Western blot the protocol of silencing and EGF
treatment (40 min) has been performed in biological triplicate leading to
the extraction of total RNA, polysomal RNA and subpolysomal RNA (the
last two of these RNA classes have been obtained from cytoplasmic sucrose
gradient separated fractions). All extracted RNAs have been hybridized on
the Agilent-Whole Human Genome Microarray 4x44K platform to obtain
gene expression proles and to compare the signicant dierences.
Results and discussion. To identify translationally regulated RNAs,
gene expression variations derived from polysomal (translatome proling)
and subpolysomal RNA has been compared with those obtained from to-
tal RNA (transcriptome proling) by hybridization of RNA populations
on microarrays. In EGF treated HeLa cells have been obtained 693 dier-
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entially expressed genes (DEGs) only in transcriptome proling and 1785
DEGs only in translatome proling, with an overlapping of 226 (8.4%)
genes, conrming an extensive uncoupling between transcribed RNA vari-
ations and RNA translation eciency changes. In 4E-T silenced and EGF
treated HeLa cells, 593 DEGs have been obtained for transcriptome and
430 DEGs for translatome, with an overlapping of 70 (6.4%) genes. In
comparison with EGF treated HeLa cells, the overall reduction of DEGs,
especially at the polysomal level can be imputed to P-bodies disassemblage
obtained by 4E-T silencing. In Dicer silenced and EGF treated HeLa cells
1687 DEGs have been obtained for transcriptome and 1282 DEGs for trans-
latome, with an overlapping of 109 (3.5%) genes, demonstrating a general
shift of post-transcriptionally regulated genes, especially if we look at the
identity of the top up-regulated polysomal genes. This uncoupling has been
observed for all the experiments also examining the overlapping degree be-
tween the ontological terms associated to the populations of transcriptional
and translational DEGs. By interrogating the main biological ontologies,
the overlapping degree between the ontological terms associated to the pop-
ulations of transcriptional and translational DEGs is extremely reduced in
all the experiments, even null in Dicer silencing. Conclusions This ex-
perimental work conrms the general and profound uncoupling between
transcriptome and translatome due to operative intelligence of polysomal
machinery. A candidate able to trigger an expression reprogramming at the
polysomal level and able to modulate this uncoupling has been identied
with P-bodies compartment, where RNAs are transported by interacting
RNA-Binding Proteins (RBPs) and microRNAs (miRNAs). This hypoth-
esis has been studied by 4E-T and Dicer silencing, two key genes involved
in P-bodies formation and in miRNA pathway.
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4.1 Experimental design
Proliferative induction triggered by Epidermal Growth Factor (EGF) after
serum starvation in HeLa cells has been chosen as biological model. The
reference control consists in serum starved HeLa cells without EGF treat-
ment, while the strong proliferative signal condition consists in HeLa cells
treated with EGF for 40 min, as shown in gure 4.1. The "EGF release
from starvation" protocol was carried out following the instructions given in
[39] and [40]. Total RNA and polysomal/subpolysomal RNA are extracted
from cells in each condition and hybridized on the Agilent-Whole Human
Genome Microarray 4x44K platform to obtain gene expression proles and
to compare the signicant dierences. The goal is to observe signicant
changes in RNA levels in the two conditions and compare dierences de-
tected by transcriptome analysis with those detected by translatome anal-
ysis. Each gene falls in one of these possible outcomes:
 no change with EGF treatment
 signicant changes detected only in total mRNA
 signicant changes detected only in polysomal mRNA
 signicant changes detected both in total and polysomal mRNA
Post-transcriptional alterations of this model were achieved through
siRNA mediated silencing of genes selected for their relevance in the two
main post-transcriptional mechanisms theoretically capable of generating
widespread uncoupling: p-bodies and the miRNA pathway.
 p-bodies disassembly through 4E-T silencing, as reported by [41] and
[42]
 p-bodies increase in size and number through XRN1 silencing, as re-
ported in [43] and [44]
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Figure 4.1: HeLA cells are treated with EGF: cellular extracts are
collected at time t=0 and t=40, total RNA, polysomal RNA and sub-
polysomal RNA are hybridized to Agilent microarray and signicant
dierences between the two conditions are detected. mRNA levels for
each gene can either be unaected or aected by EGF treatment, in
the latter case we dene these genes DEGs. Comparing transcriptome
and translatome mRNA levels, DEGs can be found just one of the two
analyses (uncoupling) or in both.
 miRNA pathway suppression through Dicer silencing, as reported by
[45] and [46]
The rst step of this work has been setting the best experimental con-
dition, especially for silencing protocol, to have the maximum silencing for
4E-T, XRN1 e Dicer. We set the following parameters:
 transfection time
 ratio between concentration of siRNA and Dharmafect
 serum starvation time
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The degree of silencing has been checked at the protein level by Western
blot, as shown in gure 4.2. We found the best transfection time to be
48h-72h with ratio siRNA-dharmafect equal to 100nM-2micrograms-mL
for 4E-T and Xrn1 silencing, 75nM-2micrograms-mL for Dicer silencing.
Serum starvation time before EGF treatment was set to 12h. From this
last western blots we checked if the silencing was eective also after EGF
treatment (40 min). The results show that silencing has been maintained.
Residual expression percentages, shown in gure 4.2, are 2-4% for 4E-T,
24-30% for XRN1 and 11-12% for Dicer. Since XRN1 silencing was clearly
less ecient than 4E-T and Dicer, we decided to not use it for the following
experiments.
Figure 4.2: Silencing eciency, expressed as percentage of residual ex-
pression, has been measured at the protein level for 4E-T, XRN1 and
DICER with western blots, before and after EGF treatment.
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After evaluating the degree of silencing at the protein level by Western
blot, the protocol of silencing and EGF treatment (40 min) was performed
in biological triplicate to extract total RNA, polysomal RNA and sub-
polysomal RNA. Figure 4.3 shows polysomal proles obtained from HeLa
cells after sedimentation through sucrose gradient centrifugation. For the
not silenced sample in the rst column (Mock) after EGF treatment we can
observe the disappearance the 80s peak and an increase of polysomal peaks.
For the 4E-T silenced sample we can observe a decrease of polysomal peaks
in both EGF treated and not treated samples, and disappearance of the 80s
peak probably due to ribosome recruitment. For the Dicer silencing sam-
ple, an increase in both monosomal and polysomal peaks can be observed
after EGF treatment. It is important to stress that these rst experimental
results agree with the general results we will get from microarray signals,
in terms of number of dierentially expressed genes detected in the three
samples.
4.2 Experimental procedures
The comparison between transcriptional and polysomal proling was used
for the discovery of general and mRNA-specic changes in the translation
state of the serum starved HeLa cells transcriptome in response to EGF
stimulus. To identify translationally regulated mRNA molecules, gene ex-
pression signals derived from the polysomal and subpolysomal RNA pop-
ulations were compared by microarrays analysis to those obtained from
unfractionated total RNAs. Polysomal RNA, subpolysomal RNA and to-
tal RNA were isolated from HeLa cells serum starved and treated with
EGF. Cells lysates were collected before (t = 0 min) and after (t = 40
min) EGF treatment. All experiments were run in biological triplicates.
HeLa cells were seeded on adherent plates and serum starved for 12h
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Figure 4.3: Polysomal proles, measured as 254nm absorbance after
sucrose gradient centrifugation of HeLa extracts before and after EGF
treatment. Without silencing (Mock) an increase in the peak corre-
sponding to the polysomal fraction and a corresponding decrease in
the 80s peak are observed upon EGF treatment. With 4E-T silencing,
both 80s and polysomal peak are not aected by EGF treatment. On
the contrary, with Dicer signalling both 80s and polysomal peaks show
an increase with EGF treatment.
with DMEM, 0.5% FBS, 2mM glutamine. Cells were treated for 40 minutes
with recombinant human epidermal growth factor (hEGF) at nal concen-
tration of 1 microgram/ml. HeLa cells were cultured in Dulbecco Modied
Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS),
2mM glutamine, 100 units/ml penicillin, and 100 mg/ml streptomycin at
37 C in a humidied atmosphere of 5% CO2.
Total RNA was extracted using TRIZOL reagent according to the man-
ufacturer's protocol. Briey, the aqueous phase was used for RNA precip-
itation with an equal volume of isopropanol. The RNA pellet was washed
once with 75% ethanol, then air-dried and re-dissolved in 20 microliters
of RNase-free water. RNA was quantied using a spectrophotometer and
its quality was checked by agarose gel electrophoresis and by Agilent 2100
Bioanalyzer platform, following the manifacturers guidelines for sample
preparation and analysis of data (Agilent 2100 Bioanalyzer 2100 Expert
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User's Guide 1.
For polysomal extraction, cells were washed once with phosphate buer
saline (PBS) and treated directly on the plate with 300 l lysis buer [10
mM NaCl, 10 mM MgCl2, 10 mM TrisHCl, pH 7.5, 1% Triton X-100, 1%
sodium deoxycholate, 0.2 U/microliter RNase inhibitor (Fermentas) and
1 mM dithiothreitol] and transferred to an Eppendorf tube. After a few
minute incubation on ice with occasional vortexing, the extracts were cen-
trifuged for 10 min at 12000 g at 4C. The supernatant was stored at 80C
or loaded directly onto a 1550% linear sucrose gradient containing 30 mM
TrisHCl, pH 7.5, 100 mM NaCl, 10 mM MgCl2, and centrifuged in an Sor-
vall rotor for 120 min at 40000 rpm. Polysomal and subpolysomal fractions
were collected monitoring the absorbance at 254 nm and treated directly
with proteinase K. After phenolchloroform extraction and isopropanol pre-
cipitation, polysomal RNA was resuspended in 30 microliters of water and
then repuried with RNeasy kit (Qiagen, Hilden, Germany). RNA quality
was assessed by agarose gel electrophoresis and the Agilent 2100 Bioana-
lyzer platform.
Microarray hybridization, blocking and washing were performed accord-
ing to Agilent protocol: One-Color Microarray-Based Gene Expression
Analysis (Quick Amp Labeling)2.
Hybridized microarray slides were scanned with an Agilent DNA Mi-
croarray Scanner (G2505C, Agilent Technologies, Santa Clara, CA) at 5
micron resolution with the manufacturers software (Agilent ScanControl
8.1.3). The scanned TIFF images were analyzed numerically using the Ag-
ilent Feature Extraction Software version 10.7.7.1 according to the Agilent
standard protocol GE1-107-Sep09.
1http://www.agilent.com
2https://www.chem.agilent.com/Library/usermanuals/Public/G4140-90040.pdf
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Figure 4.4: Agilent scanned slide showing with in color scale the uo-
rescence intensity signals coming from four dierent hybridizations.
mock 4E-T Dicer
Total RNA 0 min 100% 100% 100%
Polysomal RNA 0 min 18% 27% 49%
Subpolysomal RNA 0 min 82% 73% 49%
Total RNA 40 min 100% 100% 100%
Polysomal RNA 40 min 36% 27% 51%
Subpolysomal RNA 40 min 64% 73% 51%
Table 4.1: Percentages of polysomal and subpolysomal RNA quantities
with respect to total RNA quantities, calculated on the basis of RNA
quantities (micrograms) measured with nanodrop
Figure 4.5: Microarray data have already been submitted to GEO and
accepted as satisfying the MIAME standard. The picture shows a snap-
shot of the GEO data series containing our hybridization raw and pro-
cessed signals.
Figure 4.6: Raw signals before normalization are shown for each ar-
ray belonging to the EGF induction experiment without any silencing.
Analogous graphs were obtained for the arrays belongigng to the 4E-T
silencing experiment and the Dicer silencing experiment.
Figure 4.7: Distribution of raw intensity signals associated to detec-
tion calls of Agilent features: Absent, Present and Marginal, the last
of which included unreliable spots whose signals were removed from
following analyses.
Figure 4.8: Percentages of Agilent features associated to dierent cat-
egorical values of detection call: Absent, Present and Marginal. Each
bar represent a single hybridization. Data are visualized only for arrays
belonging to the EGF experiment without any silencing. The percent-
age of absent features is inuenced by the level of background signal
on the array, which can vary according to experimental hybridization
conditions.
Figure 4.9: Histogram of the number of Present calls associated to
each feature in the 18 experiments belonging to the EGF induction
experiment without any silencing (Mock). The majority of features
has 18 out of 18 Present calls. The ltering procedure removes features
without 2 out of 3 Present calls in the biological replicas of at least one
out of six experimental conditions.
Figure 4.10: Histogram of the number of Present calls associated to
each feature in the 18 experiments belonging to the EGF induction
experiment without any silencing (Mock) after the ltering procedure.
11025 features were called as Absent in the majority of hybridizations
and did not fulll the ltering requirements described before, therefore
they were removed from the analysis.
Figure 4.11: Distribution of array signal intensities after ltering of ab-
sent features, quantile normalization and correction of signals according
to RNA quantities listed in table 4.1
Figure 4.12: The distributions of log2 Fold Changes for the 30075 fea-
tures considered after ltering of absent ags. The distribution of total
RNA fold changes (transcriptome) is centered around 0, while the dis-
tribution of polysomal fold changes is centered around 1, reecting the
observed increase in polysomal content of HeLa cells after EGF treat-
ment. On the other hand, the distribution of subpolysomal fold changes
is centered around -0.5. The distribution of polysomal fold changes is
also more dispersed, and this is reected by the higher number of dif-
ferentially expressed genes detected at the polysomal level.
Figure 4.13: The distributions of log2 Fold Changes for the 29950 fea-
tures considered after ltering of absent ags.All the three distributions
are centered around 0, polysomal fold changes are still more dispersed.
Figure 4.14: The distributions of log2 Fold Changes for the 29987 fea-
tures considered after ltering of absent ags. All the three distribu-
tions are centered around 0 and have the same level of dispersion.
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Figure 4.15: The gure shows up-expressed and down-expressed genes
upon EGF treatment, identied as dierentially expressed genes by
RankProd.
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Appendix A
The USER Ontology
The USER (Untranslated Sequence Elements for Regulation) ontology is a
structured controlled vocabulary designed to describe post-transcriptional
regulation mechanisms of gene expression, which take place in every cell in
order to control protein production. It has been designed for the annota-
tion and classication of transcripted but untranslated sequence elements,
for example 3' and 5' untranslated regions (UTR) on mRNAs or noncoding
RNAs, involved in post-transcriptional controls. It provides a standardized
set of terms, denitions, relationships and axioms that facilitate the for-
mal and consistent analysis of data about post-transcriptional regulation
and that will make possible the automated reasoning over their contents.1
This ontology has been developed, together with the results of both com-
putational and experimental analyses, as a basis to create a new bioinfor-
matics knowledgebase which will enable the generation of predictions on
the probability that a particular mRNA molecule is post-transcriptionally
regulated. The necessity of such an instrument has increased after the pro-
gressive discovery in the last years of the inuence of post-transcriptional
controls, such as the microRNA expression silencing system, on gene ex-
pression and other important cellular mechanisms. An important goal for
this database will be the collection and the integration of dierent types
1http://www.obofoundry.org/
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of data about possible controls aecting mRNA molecules (sequence and
structural data coming from appendix ??, presence of particular motifs or
three-dimensional folds, expression data from polysomal proling experi-
mentscollected in chapter 3 and in appendix B, and generated in chapter 4.
These data sets have to be connected and merged into a single functional
context to allow the analysis of their correlation, and a useful way to struc-
ture and connect data elements avoiding redundancy is the development
of an ontology that represents and conceptualizes particular knowledge
domains. The general structure of the ontology, with classes and prop-
erties, has been dened. A rst draft of the ontology (USER-OBO) has
been written following the OBO foundry guidelines (the Open Biomedical
Ontologies Foundry is a collaborative project with the goal of creating a
suite of reference ontologies in the biomedical domain) [47]. This version
is interoperable and orthogonal to other OBO ontologies such as the Gene
Ontology (the most known and used bio-ontology: a controlled vocabu-
lary to describe gene and gene product attributes in any organism)2 or
the Sequence Ontology (an ontology suitable for describing features and
attributes of biological sequences)3. As a second step the USER ontology
has been manually translated in the OWL-DL Knowledge Representation
language (USER-OWL).
A.1 Use of biomedical ontologies
Ontologies are specic (theoretical or computational) artifacts expressing
the intended meaning of a vocabulary in terms of primitive categories and
relations describing the nature and structure of a domain of discourse.
Biologists have always classied the phenomena they observed in the bi-
ological world around them (medieval bestiaries, lists of ways in which
2http://www.geneontology.org/
3http://www.sequenceontology.org/
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people died, Linnaean classication of species), but only the advent of
bioinformatics has caused the birth of the rst computer-based conceptual
models addressed to the biomedical knowledge domain, in order to share
unambiguously what is known about the world of biomedicine. The Gene
Ontology, due to community involvement, clear goals, limited scope, simple
structure, continuous evolution and immediate applications, has been the
most successful biomedical ontology, being responsible of the publication
of more than half of all the ontology papers in Pubmed in the last years
[48], [49]. A map of some well known biological ontologies is represented
in gure A.1, taken from 4.
Figure A.1: The image shows a map of connections between biological
knowledge domains modelled by some of the most known biological
ontologies and centered aroung the Gene Ontology.
4http://www.w3.org/2007/Talks/0403-Tampere-IH/
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A.2 Comparison between OBO and OWL
Dierent Knowledge Representation languages provide dierent means to
make statements about knowledge to be captured. Dierent languages
have varying expressivity and computational properties according to their
semantics. The comparison between OBO and OWL formats can be con-
sidered a symbol of the broader comparison between two alternative ap-
proaches towards ontologies, adopted respectively by biologists and com-
puter scientists. In this sense the comparison can be properly introduced
by this citation from [50]:
"The bio-ontology community falls into two camps: rst biology domain
experts, who actually hold the knowledge we wish to capture in ontologies;
second, ontology specialists, who hold knowledge about techniques and best
practice on ontology development. In the bio-ontology domain, these two
camps have often come into conict, especially where pragmatism comes
into conict with perceived best practice (for example the insistence of com-
puter scientists on a well-dened semantic basis for the Knowledge Repre-
sentation language being used)."
Today the Gene Ontology and a signicant number of bio-ontologies
are in the OBO-format, which has evolved to support the needs of the bio-
ontologies under the Open Biomedical Ontologies umbrella and aims to
have human readability, ease of parsing, extensibility and minimal redun-
dancy. The Gene Ontology and all other OBO ontologies are formalized
as a Directed Acyclic Graphs (DAG), a structure with nodes (classes) and
edges (relations). Every term has a denition given in natural language,
not intended to be used by an automated reasoning tool to draw new infer-
ences. The OBO-format is a very successful format for biomedical ontolo-
gies and it's used by most GO-based data analysis tools. The drawback is
that ontologies in the OBO format typically lack computational denitions
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to dierentiate a term from other similar terms. This leaves the task of
maintaining ontology integrity entirely on human developers because tools
such as automated reasoners can't be used properly. The OBO-format is
moving towards an increased expressiveness and the new version, OBO 1.2,
even if it has not yet been adopted by most OBO ontologies, can support
some reasoning but it still lacks OWL expressiveness and a DL reasoner.
As pointed out in [51] once OBO ontologies are converted to OWL, they
are available to a wider user community and they can make use of au-
tomatic reasoners, especially when logical statements such as necessary
and sucient denitions for classes are added. A mapping between OBO
format les into appropriate OWL constructs and predened annotation
tags is being attempted by the National Center for Biomedical Ontologies
(NCBO) 5 in a joint eort of OBO developers and ontology experts. For
the USER ontology this mapping has been performed manually.
A.3 The USER-OBO Ontology
The USER-OBO ontology is structured as a directed acyclic graph (DAG),
which is similar to a hierarchy, but diers in that a child term can have
many parents, or less specialized, terms. New terms and their location
within the ontology are proposed and then approved or rejected by an open
group of individual on the web. The USER-OBO ontology has been devel-
oped and can be viewed using the editor software OBO-Edit [52]. Basic
categories and relations in this format are necessary for the USER-OBO
ontology to co-exist and co-operate with other OBO foundry ontologies.
Ontological relations have not been chosen arbitrary: even if an "is-a"
overloading can lead to overgeneralization or reduction of sense, the choice
has been made according to the current standard use of biological ontolo-
5http://bioontology.org/
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gies.
A.3.1 OBO terms
In the OBO format, the USER ontology consists of a controlled vocabu-
lary of terms which represent classes, and a restricted set of relationships
between these terms. Terms are organized in a hierarchy. Each entry in
OBO ontologies consists of these anatomical parts:
Unique ID: a numerical identier (e.g. USER: 0000003)
Term name: dened following name conventions (e.g. mRNA)
Synonyms: variant names that have the same meaning as the term (e.g.
messenger-RNA). In the latest version of the OBO format there is the
possibility to specify precision and coverage of a synonym selecting
one option among: "related", "exact", "narrow" or "broad".
Textual denition: a human-readable and not computable denition that
concisely states the biological meaning of the term (e.g. RNA molecule
which contains the information ribosomes will use to produce a pro-
tein. It doesn`t contain introns. It includes UTRs and coding se-
quences).
Database reference: reference of the denition: an organization, a book,
a PubMed ID or some other source. (e.g. PMID17544019)
Parentage: computer readable parent-child relationships with other terms
of the ontology (e.g. is-a: USER:0000002)
In order to reduce lexical confusion and render the ontology more computer-
friendly, the terms of the USER ontology have been dened following some
naming conventions, commonly shared by the other OBO ontologies:
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 Term names are always singular, as they represent universals, not
specic instances of concepts.
 Term names do not include spaces: underscores are used to separate
the words in phrases (for example aminoacid-structure-motif).
 Numbers are spelled out in full (for example three-prime-UTR).
 Periods, points, slashes, hyphens and brackets are not allowed in term
names.
 Common abbreviations, used in the molecular biology community, can
be included in term names (for example snoRNA, RRM).
Synonyms are employed to record the variant names that have the same
meaning as the term. Their usage facilitates the searching of the ontology.
There is no limit to the number of synonyms a term can have, and they
don't need to adhere to the previous naming conventions.
A.3.2 OBO relationships
While a controlled vocabulary is merely a collection of predened terms
that are used to describe the data, an ontology also formally species the
relationships between its terms. This feature makes the data, labeled with
the terms of an ontology, an admissible input for a software capable of log-
ical inference. Currently the USER-OBO ontology uses three basic kinds
of relationships between its terms: is-a, part-of and associated-with. The
rs two relationships are dened in the OBO relationship types ontology,
the last one is still a matter of discussion in the Sequence Ontology de-
velopment but, providing a way to integrate heterogeneous data into the
single context of post-transcriptional regulation of gene expression, it is
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particularly signicant in the light of the goals this ontology wants to pur-
sue. The information introduced by this relation can be more eciently
conveyed using OWL-DL object properties.
is-a: it is a transitive, reexive, anti-symmetric relationship. is-a is a sim-
ple class-subclass relationship, where A is-a B means that A is a sub-
class of B; for example, miRNA (microRNA) is-a ncRNA (non coding
RNA). This relationship has a directional nature and establishes a
sort of hierarchy among the terms of the ontology: inferences as to
what something is proceed from the leaves towards the root of the
ontology.
part-of : it is a transitive, reexive, anti-symmetric relationship. This re-
lationship belongs to mereology, the discipline dealing with parts and
their respective wholes. C part-of D means that whenever C is present,
it is always a part of D, but C does not always have to be present. For
example a motif is part-of a biological-sequence: motifs are always
part of a biological sequence, but not all biological sequences have
motifs. Part-of relationships are not valid in both directions: every
part-of relationship logically implies the inverse has-part relationship
between the two terms.
associated-with: it is a symmetric relationship. It means being related
to or accompanying, joined. Whenever there is strong evidence sug-
gesting that the presence of a particular motif (a continuant) is highly
correlated to the presence of one or more molecular functions (pro-
cesses) in the cell, such as the bond to another molecule, then that
function is associated with that motif, and vice versa. Any motif can
also be associated with an eect on the behavior of the cell (for ex-
ample the biological processes which are aected by the binding of a
particular molecule to a binding motif, are associated with that mo-
66
A.3. THE USER-OBO ONTOLOGY
tif, and vice versa). This relationship is not genuinely ontological, but
dependent on experimental assumptions and methods [53].
A.3.3 Content description
The USER ontology presently contains more than one hundred terms. This
section provides, with the help of illustrations and denitions, a general de-
scription of the shape, the organizational choices and the main contents of
the USER ontology. Dierent portions of the ontology, each representing
an important branch of biological annotation, will be presented and dis-
cussed: the path to the ontology root (the biological-sequence term) will
always be present in the pictures, in order to let the reader orient himself.
Kinds of biological sequences: the two main kinds of biological sequence
taken into consideration are transcripts (RNA molecules generated
from DNA through the transcription process) and polypeptide chains
(generated from mRNA through the translation process). DNA is not
considered, as being not concerned in post-transcriptional regulations.
Figure A.2: A section of the USER Ontology describing dierent kinds
of non-coding RNAs.
Kinds of aminoacid motifs: motifs can be dened as the functionally
relevant parts of biological sequences. The aminoacid motifs selected
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and considered in the USER ontology are the protein domains be-
lieved to be involved in post-transcriptional controls and thus dealing
directly with RNA molecules. A rich classication of these domains
can be found in literature [13], [54].
Kinds of RNA motifs: RNA motifs can be classied into two broad
classes depending on the feature which is functional and evolution-
ary conserved: sequence or structure. RNA sequence motifs and their
denitions are taken from the Transterm database [55], which provides
access to mRNA sequences and regulatory elements (65 dierent mo-
tifs are contained in the latest Transterm version). Many of these
motifs are primarily located in the 5' or 3' UTRs of mRNA sequences:
they have been reported less commonly in coding sequences. RNA
main structural motifs have been extracted from the SCOR database
6, the NDB database 7 and the RNA Ontology Consortium website 8.
Motif functions: by denition every biological motif can be joined to spe-
cic molecular functions, which establishes the biological role of the
motif and why it has been selected and conserved by evolution. As the
ontology is centered on post-transcriptional mechanisms concerning
mRNA, binding functions are primarily considered. The three ma-
jor binding classes, RNA-binding, small-molecule-binding or protein-
binding, specify the biological molecule with which the binding motif
interacts. This portion of the USER Ontology is integrabile with the
Molecular Function tree in Gene Ontology.
Post-transcriptional eect : motifs in certain mRNAs have been shown
to have a positive or negative eect on many functions and post-
translational controls in cells, described in this section of the ontology.
6http://scor.lbl.gov/
7http://ndbserver.rutgers.edu/
8http://roc.bgsu.edu/
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Figure A.3: A section of the USER Ontology describing the kinds of
motifs which can be traced in RNA sequences.
A.4 The USER-OWL Ontology
The USER ontology has been rst built in OBO format using the OBO-
Edit software, and then it has been recast in OWL-DL language using the
Protg Software 9. OWL-DL is a sub-language of OWL (Web Ontology
Language) 10 characterized by computational tractability and an expres-
siveness which falls between that of OWL-Lite and OWL-Full and is based
on Description Logics. OWL-DL allows a Description Logic Reasoner to
check the consistency of the ontology and automatically compute the on-
tology class hierarchy. OWL ontologies consist of Individuals, Properties
and Classes. Individuals in the USER ontology are principally RNA se-
quences corresponding to real transcripts (any biological species can be
considered). Classes are sets which contain individuals, described when
possible using formal descriptions that state precisely the requirements for
9http://protege.stanford.edu/
10http://www.w3.org/TR/owl-features/
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Figure A.4: Screenshot taken from the OboEdit software showing an
overall representation of the USER-OBO ontology.
membership of the class. Classes in the USER-OWL ontology correspond
to OBO terms in the USER-OBO ontology: class names are thus directly
created from OBO term names, following the same name conventions. Also
the superclass-subclass hierarchical structure follows the same is-a struc-
ture found in the USER-OBO ontology, while part-of and associated-with
relations have been translated in dierent OWL properties. The following
sections introduce and discuss the new features introduced in the USER
ontology during the OWL-DL conversion, thanks to the increased expres-
sivity of this language.
A.4.1 Disjointness and covering constraints
While in the OBO format if a parent class has more than one child there
is no way to distinguish between possibly overlapping and disjoint classes,
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OWL-DL allows this specication. In the USER-OWL ontology this spec-
ication has been added every time a supporting reliable biological knowl-
edge is present. For example mRNA and ncRNA are disjoint classes of
RNA sequences because an instance of mature-transcript can't belong to
both these two classes. On the contrary, inside the ncRNA class, miRNA
and siRNA haven't been specied as disjoint because the real boundary
between these two categories of functional RNAs hasn't been outlined
yet, both at the conceptual level and at the instance levels. This means
that some individuals belonging to both these classes could exist. For the
same reason sequence-RNA-motif and structure-RNA-motif are not dis-
joint classes. Covering constraints have been added to the USER-OWL
ontology where appropriate. If we have three classes A, B and C and
classes B and C are subclasses of class A, a covering axiom that species
that class A is covered by class B and by class C means that a member of
class A must be a member of B and-or C (class A is the union of the classes
being covered). The OBO representation doesn't allow these axioms, and
their use has been limited also in the USER -OWL ontology because such
axioms require more knowledge than is usually available in biology. For
example we can't presently be sure that every ncRNA belongs to one of
the subclasses specied in the USER ontology since other subclasses are
probably going to be discovered in the future, and therefore a covering
constraint has not been added in this case. On the contrary we can say
that a mature-transcript must be either a mRNA or a ncRNA, therefore a
covering axiom relating these three classes has been added.
A.4.2 Object properties
Object properties represent binary relationships between individuals. OWL
allows the meaning of properties to be enriched through the use of property
characteristics such as functional, inverse functional, transitive or symmet-
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ric. In OWL properties may also have sub-properties, therefore it's possible
to create hierarchies of properties. Properties may have a domain and a
range specied: a property links individuals from its domain to individuals
from its range. These are the object properties in the USER-OWL ontol-
ogy; they have been named following OWL property naming conventions.
Domain and range of each property has been specied. Each of these ob-
ject properties has a corresponding inverse property, with swapped domain
and range.
hasMotif: links an individual belonging to the class RNA-sequence or
RNA-part to an individual belonging to the class motif. Inverse prop-
erty: isMotifOf.
hasPart: links an individual belonging to the class mRNA to an indi-
vidual belonging to the class RNA-part. This property has three
sub-properties: hasCDS, hasThreePrimeUTR and hasFivePrimeUTR,
which link an individual belonging to the class mRNA to an individual
belonging respectively to the class CDS, the class three-prime-UTR
and the class ve- prime-UTR. These three subproperties are func-
tional, since every mRNA sequence has one and only one CDS, three
prime UTR and ve prime UTR. Inverse property: isPartOf, isCDSOf,
isThreePrimeUTROf, isFivePrimeUTROf.
hasFunction: links an individual belonging to the class motif to an indi-
vidual belonging to the class function. Inverse property: isFunctionOf.
hasEect: links an individual belonging to the class motif to an individual
belonging to the class eect. Inverse property: isEectOf.
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A.4.3 Property restrictions
In OWL properties are used to create restrictions, which help to dene
classes in a computer understandable way. Restrictions are used to restrict
the individuals that belong to a class. Quantier restrictions are composed
of a quantier (commonly the existential quantier or the universal quan-
tier) a property and a ller (usually a class or a composition of classes).
Existential restrictions have been added to the USER-OWL ontology: for
example an existential restriction has been added to the class motif speci-
fying that it must be a motif of some RNA-sequence (along the isMotifOf
property). These are other examples of existential restrictions used in the
USER-OWL ontology:
 Class function must be a function of some motif (along the isFunc-
tionOf property)
 Class eect must be an eect of some motif (along the isEectOf
property)
 Class aminoacid-motif must be a motif of some CDS (along the isMo-
tifOf property)
Universal restrictions are more dicult to assign because they require
a more precise underlying biological knowledge, with respect to existential
restrictions. These are examples of universal restrictions used in the USER-
OWL ontology:
 Class RNA-sequence has only motifs which belong to the motif class
(along the hasMotif property)
 Class motif has only functions which belong to the function class
(along the hasFunction property)
73
APPENDIX A. THE USER ONTOLOGY
 Class CDS is only part of individuals belonging to the mRNA class
(along the isCDSOf property)
These restrictions have been inferred from the textual denitions present
in the USER-OBO ontology and have been added as necessary condi-
tions to primitive classes in the ontology. They represent a way in which
human-readable knowledge can be to some extent converted into computer-
readable knowledge. The hope is that, as biological knowledge grows and
becomes more accurate, more information can be poured into formal re-
strictions.
A.4.4 Dened classes
Necessary and sucient conditions have not been used in the original OBO-
derived USER ontology classes. Some dened classes have been created to
facilitate the extraction of biologically meaningful information from the
ontology and to help the creation of restrictions which dene other classes.
For example it is very useful to dene a subclass of motif called mRNA-
binding-motif, whose members are all motifs which have at least an mRNA-
binding function. This condition is necessary and sucient to dene the
RNA-binding-motif class and converts this from a Primitive Class into a
Dened Class, on which the DL-reasoner can perform automatic classi-
cation. The dened class mRNA-binding-motif is useful also as ller in
restrictions which describe other classes: for example an individual belong-
ing to the class miRNA or siRNA must have some mRNA-binding-motif
(existential restriction along the hasMotif property). Another biologically
interesting dened class is composed of mRNA which can be regulated
at the same time by microRNAs and by RNA binding proteins. These
mRNA must possess at least one or more miRNA-binding-motif and at
least one protein-binding-motif: we can call this class mixture-regulated-
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mRNA. This class is dened as a subclass of mRNA having two existential
restrictions acting along the hasMotif property.
A.4.5 Annotation properties
Natural language denitions associated with terms in the USER-OBO on-
tology cannot be translated directly in OWL-DL axioms. However it is
possible to capture them using annotation properties: OWL allows classes,
properties and individuals to be annotated with various species of infor-
mation, for example comments or references to other resources. Assertions
on annotation properties act as comments and are not taken into account
from a DL point of view, yet they can be displayed to the biologist as
a piece of information on classes, just as in OBO ontologies. The most
suitable annotation property for labeling a term with its id is rdfs:label,
while the most suitable annotation property for labeling a term with its
textual denition is rdfs:comment. The annotation rdfs:seeAlso can be
used to identify related resources. Synonyms from the OBO format can be
traduced using assertions on annotation properties or creating equivalent
classes.
A.4.6 Populating classes with individuals
Populating USER-OWL classes with real biological entities implies the an-
notation of biological RNA sequences. This work is being accomplished
for the human genome using several bioinformatics resources such as the
already seen Transterm [55] or the Ensembl Genome Browser [56]. At the
end of this process the RNA-sequence class will contain all the human tran-
scribed sequences currently known. Every individual is currently identied
by a unique ENSEMBL transcript ID (e.g. ENST00000229384). The fol-
lowing tab summaries the number of individuals populating some of the
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mature-transcript subclasses of the USER-OWL ontology:
Class Individuals
mRNA 21528
miRNA 1472
rRNA 333
snoRNA 758
snRNA 1288
Table A.1: Number of individuals, retrieved from the Ensembl Genome browser,
belonging to dierent classes of mRNAs and ncRNAs.
The next step is the creation of relationships between individuals, ac-
cording to the object properties of the USER-OWL ontology. Once the
ontology classes have been populated with individuals and relationships,
hasValue restrictions can be used in class descriptions. For example there
is the possibility to create classes of all the motifs associated to any indi-
vidual mRNA sequence along the property isMotifOf.
A.4.7 Use of the RACER reasoner
Ontologies described using OWL-DL can be processed by a reasoner, one
of whose main services is consistency checking: based on the conditions of
a class the reasoned can check whether or not it is possible for the class to
have any instances: a class is considered inconsistent if it cannot possibly
have any instances. The DIG compliant reasoner RACER [57] has been
applied to check the USER-OWL ontology consistency: corrections have
been made in order to make the current version of the ontology free of any
inconsistency. Another standard service oered by the reasoner is to test
whether or not one class is a subclass of another class, relying upon class
denitions: by performing such tests on all the classes of the ontology the
reasoner can automatically compute the inferred ontology class hierarchy.
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Figure A.5: Screenshot taken from the Protg software showing neces-
sary and sucient conditions for the class mixture-regulated-mRNA.
This inferred hierarchy can be compared to the already existing asserted
hierarchy. The RACER reasoner has been applied to the USER-OWL
ontology to perform automatic classication.
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Bayesian inference of RBP-mRNA
interactions
Translational controls of gene expression are strongly mediated by RNA-
binding proteins (RBPs), therefore change over time among dierent con-
ditions in polysomal mRNA proles should be mirrored by changes in con-
centrations of eector RBPs.
We rst decided to consider a linear model relating changes in RPB
polysomal levels to the dierence between changes in polysomal RNA con-
centrations and changes in total RNA concentrations. We assume also that
RBP protein levels run parallel to changes in RBP polysomal concentra-
tions. The goal of the analysis is inferring the network structure, i.e. the
interactions among RBPs and mRNAs.
xit(t)  xip(t) =
X
j
Aijy
j
p(t) +  (B.1)
We considered also the possibility of a linear model relating directly
changes in RBP polysomal levels to changes in polysomal RNA concen-
trations, without considering total RNA concentrations. In this way the
model turns into:
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xip(t) =
X
j
Aijy
j
p(t) +  (B.2)
Another proposal is to use as input parameter the quantitative uncou-
pling values determined after principal component analysis on polysomal
and total fold change values, as seen in chapter 3
PC2ip(t) =
X
j
Aijy
j
p(t) +  (B.3)
The last option is to use as independent variable the ratio between
sub-polysomal levels and polysomal levels (subtracting polysomal levels
from total levels in all the datasets where the sub-polysomal signal is not
available).
xip(t)  xis(t) =
X
j
Aijy
j
p(t) +  (B.4)
The outcome of this work will be the identication of putative actions
of given RBPs on translational eciency modications of given mRNAs,
detected by comparison between translatome and transcriptome proling
techniques. It's quite relevant to note that the inferred action of RBPs on
mRNAs is not dependent on their direct phisical interactions during trans-
lation. This statement justies the observed degree of discrepancy between
the model outcomes and some RIP-chip experimental results. Following
an accepted model of translational regulation which considers translation
initiation the fundamental rate limiting step of protein synthesis, these
RBPs should be able to produce uncoupling between transcriptome and
polysomal mRNA variations by mainly aecting their translational ini-
tiation eciency. Described molecular mechanisms include: subtraction
of mRNA availability for the formation of the closed loop for polysomal
mRNA buering and increased eciency of assembly of pre-initiation com-
plex, or 5'UTR scanning for polysomal mRNAmagnication of steady state
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variations. Note that in both cases the proteins involved as eectors are not
necessarily RBPs (e.g. eIF4G). In these cases the expected eect should
be less relying on phisical protein-RNA interactions (for example TCD4 in
mammals is a repressor of eIF4E helicase, which on turn entangles mRNAs
5'UTRs increasing translational initiation eciency).
Figure B.1: This scheme represents the problem of inferring specic
connections between mRNAs and RNA binding proteins able to reg-
ulate, directly or indirectly, their translation eciency. Inference on
post-transcriptional networks is based on high-throughput variables,
such as polysomal proling signals coming from the experiments de-
scribed in chapter 3.
B.1 Clustering of RBPs
Since observations (polysomal data coming from dierent experiments) are
less than the number of RBPs (a few hundreds), an idea is to cluster the
RBP proles. The updated model would be the following:
xit(t)  xip(t) =
X
j
Aijc
j
p(t) +  (B.5)
yip(t) 
KX
i=1
iN (ci(t); 2i ) (B.6)
Possible RBP clustering criteria are:
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 a priori clustering using sequence homology information
 a posteriory clustering using behaviour similarity in polysomal proles
Proteins to be included as regulators of translational eciencies could
include not only RNA binding proteins, but also more general translational
modulators, such as translation initiation factors or proteins involved in
pathways known to inuence post transcriptional regulation such as the
mTOR pathway.
B.2 Graphical model
Figure B.2 represents the graphical model of the Bayesian network adopted
to extract from polysomal data putative RBP-mRNA connections.
Figure B.2: Bayesian network used to infer relationships between RBPs
and mRNAs
We assume that the entries in the matrix Aij are of product form 
i
j
i
j
where ij is normally distributed with mean 0 and variance 1, while 
i
j is 0
or 1 with constant probability !. This last parameter controls the expected
parsity of the network.
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The joint probability, according to the Bayesian network used to model
post-transcriptional controls, can be expressed as:
p(x; y; ; ; c; ) = p(xj; ; c)  p(yjc; )  p()  p()  p(c)  p() (B.7)
A simplied version of the model doesn't consider the clustering step:
the simplied bayesian network is represented in gure B.3.
Figure B.3: Simplied Bayesian network used to infer relationships
between RBPs and mRNAs without clustering RBPsaccording to their
similar behaviour in polysomal proling experiments.
The joint probability of the model without clustering is:
p(x; y; ; ) = p(xj; ; y)  p(y)  p()  p() (B.8)
B.3 Gibbs sampler
A Gibbs sampler can be used to estimate the joint posterior probability
over the network structure, the latent RBP primitive proles and the latent
RBP cluster allocations. For the Gibbs sampler the conditional posterior
over all the unobserved variables in the model are needed:ij; 
i
j; c; .
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p(ijjij; cj; xi; A ij;) / p(xijij; ij = 1; A ij; cj;) p(ij) (B.9)
p(ij = 1jij; cj; xi; A ij;) / p(xijij; ij = 1; A ij; cj;) p(ij = 1)
(B.10)
p(jx; y; A; c) / p(jy; c) (B.11)
p(cjjx; y; A; ;) = p(cj) p(xjA; c) p(yjc; ;) (B.12)
The equation describing how x data are modelled from y data is:
xi =
X
j
ij
i
jyj + " (B.13)
The following equation describes how the  parameters in the Gibbs
sampler are updated at each iteration:
p(ij = 1jij; cj; xi; A ij;) / p(xijij; ij = 1; A ij; cj;) p(ij = 1)
(B.14)
p(xijij; ij = 1; A ij; cj;)  N(
X
j
ij
i
jcj; ") =
1p
2"
exp
8<:  12"(xi  
X
j
ij
i
jcj)
2
9=;
(B.15)
The following equation describes how the  parameters in the Gibbs
sampler are updated at each iteration:
p(ijjij; cj; xi; A ij;)  N(m; ) (B.16)
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1
2
=
c2j
"
+ 1 (B.17)
m =
cj
"
 (xi  
X
j^ 6=j
ij^
i
j^cj^)  2 (B.18)
Update of  parameters in the Gibbs sampler is described by the fol-
lowing equation:
p(ljy; cl) =
l  exp
n 12(y   cl)2oPK
k=1 k  exp
n 12(y   ck)2o (B.19)
Update of c parameters in the Gibbs sampler:
p(cijx; y; A; ;)  N(m; ) (B.20)
1
2
=
P
j
(ij
i
j)
2
2
+
X
l
li + 1 (B.21)
m =
0B@
P
j(xj   Pi^ ji^ji^ ci^)  ijij
2
+
X
l
yl  li
1CA  2 (B.22)
B.4 Data structures
This section describes the data structures used to implement computation-
ally the Gibbs sampler.
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(B.23)
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(B.24)
X
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(B.25)
Y
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(B.26)
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O
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(B.27)

2666666664
p1
:
:
pR
3777777775
# number of RBPs
where p 2 f1:::Cg
(B.28)
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B.5 Algorithm implementation with synthetic data
In order to test the learning capability of the implemented model, synthetic
data were generated as:
 synthetic (Alfa real) are generated sampling from a normal distribu-
tion with mean=0 and standard deviation=1
 synthetic (Beta real) are generated placing 1 values for all  corre-
sponding to  absolute values above a certain quantile (modulated by
the sparseness parameter !), and placing 0 values for all other .
 synthetic c(Cluster real) are generated sampling from a mixture of
two normal distributions with mean=m and standard deviation=sd
(where m and sd are user-dened parameters)
 synthetic (Eta real) are generated with equal probability for every
RNA binding protein to belong to any cluster
 synthetic polysomal fold changes y(Y real) are generated sampling
from normal distributions with mean equal to the values of the cluster
the RNA binding protein belongs to, and standard deviation=sdy (a
user dened parameter)
yor  N(pr  co; sdy) (B.29)
 synthetic delta fold changes of transcripts x(X real) are generated
using Cluster real, Alfa real and Beta real data and adding a certain
percentage of error, dened by the errorpar parameter, on the mean
variance on delta fold change observations for every gene
 initial c and  data (Cluster start) and (Eta start) are generated ap-
plying the k-means clustering algorithm on Y real data (the number
of clusters is dened by the user)
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 initial and  data (Alfa start) and (Beta start) are created by re-
gression on X real and Cluster start data.
The algorithm shows a good learning performance on synthetic data, as
testied in gure B.4 by the ROC curve obtained on the  parameter, which
models the probability of having interaction between RBPs and mRNAs.
Figure B.4: ROC curve associated to the  parameter threshold chosen
as signicative to infer an interaction between RBPs and mRNAs
B.6 Algorithm sperimentation with yeast data
Polysomal yeast data were retrieved from literature and microarray databases
(GEO [58], ArrayExpress [59]). Following the procedure already described
in chapter 3,raw data were normalized with the RMAmethod (Robust Mul-
tichip Average) [60]. Fold changes relative to yeast open reading frames
were calculated for total and polysomal RNA proling. A brief description
of the datasets included in the analysis follows:
1. Transcript-specic translational regulation in the unfolded protein re-
sponse of Saccharomyces cerevisiae [61]. Cells are treated with DTT,
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polysomal and sub-polysomal RNA fractions are extracted and quan-
tied with Aymetrix genechips before the treatment and after 1 hour.
2. Gene expression analyzed by high-resolution state array analysis and
quantitative proteomics: response of yeast to mating pheromone [62].
Cells are treated with factor, polysomal and total RNA fractions are
extracted and quantied with custom yeast ORF microarrays before
the treatment and after 30 minutes.
3. Translation proling of yeast caf20 mutants. Wild type cells are com-
pared with mutant cells, polysomal and total RNA fractions are ex-
tracted and quantied with Aymetrix genechips.
4. Global Translational Responses to Oxidative Stress Impact upon Mul-
tiple Levels of Protein Synthesis [63]. Cells are treated with H2O2,
polysomal and total mRNA fractions are extracted and quantied
with Aymetrix genechips before the treatment and after 15 minutes.
5. Global gene expression proling reveals widespread yet distinctive
translational responses to dierent eukaryotic translation initiation
factor 2B-targeting stress pathways [64]. Cells are aminoacid star-
vated, polysomal and total mRNA fractions are extracted and quan-
tied with Aymetrix genechips before the treatment and after 20
minutes.
6. Global gene expression proling reveals widespread yet distinctive
translational responses to dierent eukaryotic translation initiation
factor 2B-targeting stress pathways [64]. Cells are treated with bu-
tanol, polysomal and total mRNA fractions are extracted and quan-
tied with Aymetrix genechips before the treatment and after 10
minutes.
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Appendix C
The mRNA relay model of gene
expression
After 40 minutes of EGF stimulation the majority of variations in gene
expression (DEGs) are seen only at the polysomal level (72.4%), and the
degree of overlapping between translatome DEGs and transcriptome DEGs
is very small (3.2%). Despite this, the over-represented GO themes are
largely overlapping (18.4% identity overlap). This is really weird. Trans-
latome reprogramming is profoundly rewiring the transcriptome program
in terms of the specic DEGs, but not in terms of potential nal phenotypic
outcomes, it is a sort of "fake reprogramming". It is something like the
nucleus is delivering the exact nal message, but this message, before ar-
riving at destination, has to change in shape without aecting the content.
This analysis suggests the existence of fake reprogramming.
From the 4E-T silencing experiment (4E-T is necessary for P-bodies
formation) we see that the "fake reprogramming" activity is disrupted by
the loss of P-bodies, because it induces a marked decrease of translatome
DEGs. Consistently with fake reprogramming, there is no change in over-
represented GO themes after inhibition of P-body formation. This exper-
iment therefore conrms fake reprogramming and locate it in P-bodies.
Another conrmation comes from the inconsistency of results we observe
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between polysomal and subpolysomal signals of the same genes. In our
analysis, these two DEGs proles are not in favour of an obvious model of
transfer of mRNAs from the subpolysomal compartment to the polysomal.
But if we assume that fake reprogramming takes place and that the newly
transcribed mRNAs after EGF stimulation are targeted to P-bodies and
subsequently degraded, we should not expect direct transfer to the polyso-
mal compartment. This analysis conrms fake reprogramming suggesting
that it involves a step of degradation (possibly in P-bodies) of the newly
synthetized mRNAs.
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down/down
up/down
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DEGs mock
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Figure C.1: Number of DEGs for the dierent classes in the mock
experiment
C.1 A model for the mechanism of fake reprogram-
ming
In this model positive variations of mRNA quantities are all "absorbed"
by P-bodies (we do not say anything here for simplicity about negative
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Figure C.2: Number of DEGs for the dierent classes in the 4-ET
silencing experiment
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Figure C.3: Number of DEGs for the dierent classes in the Dicer
silencing experiment
variations, which should inserted later in the model). This implies that ev-
ery incremental mRNA species induced in the nucleus by EGF signaling is
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Figure C.4: Percentage of DEGs for the dierent classes
Figure C.5: Movements of mock transcriptome DEGs upon 4E-T si-
lencing
directed in the cytoplasm to P-bodies. In P-bodies a completely unknown
mechanism determines the "recognition" by each entered mRNA of other
mRNAs already stored in P-bodies which are ontologically compatible with
the rst (i.e., whose protein products, altogether, perform a similar func-
tion), nally determining their release toward the polysome. The "input"
mRNA in the P-bodies is instead kept there or, most likely, degraded.
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Figure C.6: Movements of mock translatome DEGs upon 4E-T silencing
Figure C.7: Movements of mock common DEGs upon 4E-T silencing
1. What is the code for ontological compatibility
2. And how could be mRNA-mRNA recognition realized?
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Figure C.8: Movements of 4E-T transcriptome DEGs upon 4E-T si-
lencing
Figure C.9: Movements of 4E-T translatome DEGs upon 4E-T silencing
(1) There are various possibilities, but two hypotheses are the more
likely.
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Figure C.10: Movements of 4E-T common DEGs upon 4E-T silencing
1a The code is based on CDS paralogy. In this case an mRNA entering in
the P-bodies recognizes close gene paralogs, coding for members of the
same protein family. Members of the same family of proteins perform
usually similar functions, but are expressed sometimes alternatively
in dierent tissues. Verication: superimposing a paralog annotation
mask to translatome and transcriptome DEG proles should allow
decoding.
1b The code is based on 5' or 3' UTR recognition sites. In this case what
is recognized are these sites, and genes ontologically compatible share
these sites. Verication: we could start from our map of phyloge-
netic footprints (PFs) of 5' and 3' UTRs, and superimpose them to
to translatome and transcriptome DEG proles.
(2) For the (1a) hypothesis we need an activity binding to a CDS and
nding homolog CDSs. For the (1b) hypothesis we need the same activities
binding instead to PFs and nding matching ones (not necessarily homolog
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Figure C.11: A: The newly transcribed mRNA arrives at the P-body
directed by 4E-T (orange ) and interact with a preexisting mRNA/RBP
lattice by an interaction code made by cis sequences and bound RBPs.
B: The newly arrived mRNA recruits the decapping/degradation ma-
chinery because of the presence of 4E-T. C:Degradation of the newly
arrived mRNA and release of the lattice from P-bodies through an un-
known mechanism
ones). A ncRNA recognizing in trans two or more mRNA sites or an
RBP (or an RBP complex) recognizing with dierent domains two or more
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Figure C.12: Relay versus delay model
mRNA 5' or 3' UTRs could perform this. Complexes of dierent RBPs with
dierent mRNAs have already been described, sort of ribonucleoprotein
lattices present in the cytoplasm. What we need here in both cases is that
a all newly transcribed mRNAs after the EGF stimulus are targeted to
P-bodies.
b the arrival of a new mRNA in the P-body determines the release of
ontologically compatible mRNAs from the P-body.
c degradation of this new mRNA.
What is the mechanism of this process?
(a) If the targeting molecule is a protein or a complex of proteins, which
is likely, we need that this protein binds to all newly transcribed mRNAs. It
could therefore be component of the eIF4F complex, or of the exon-junction
complex, both present in all mRNAs. A very interesting candidate could
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be exactly 4E-T, the protein we have targeted just because it destroys P-
bodies. 4E-T is a predominantly cytoplasmic protein which binds to eIF4E
and directs mRNAs into P-bodies, colocalizing with the P-body decapping
factors and also negatively controlling mRNA stability [42]. 4E-T is a very
poorly studied protein (only about ten papers). 4E-T could be at least
one fundamental protein of a complex present in P-bodies devoted to the
recognition and degradation steps of fake reprogramming, involved in the
rst step of P-body transport of mRNAs once produced in the nucleus.
Targeting 4E-T is therefore an ecient way not only to disrupt P-bodies
but also to disrupt fake reprogramming, it could be the transporter of the
process.
(b) For this we need st of all a coupler between mRNAs. The coupler,
as said, could be a ncRNA, a protein or protein complex, or both. The
coupler should be able to act as a bridge between the original incoming
mRNA and the ontologically compatible mRNAs already present in the
P-body. I think that the of the two presented hypothesis for the code
the 1b, recognition by the 5' or 3' UTR sites is the most likely because it
can allow great exibility of coupling. Indeed, a CDS paralogy coupler is
only able to aggregate mRNAs of proteins belonging to the same family,
while a coupler based on 5' or 3' UTR sites has a great degree of exi-
bility, it could couple whatever types of mRNAs irrespective of their CDS
sequence. To be noted also that the rst type of coupler should be more
able to tolerate mismatches on a great variety of dierent sequences, while
the second could act on more specic and shorter sequence stretches. In
the choice between an RBP-based or a ncRNA-based coupling machinery,
RBPs could be more likely to be involved, for their exibility in forming
coupling pairs by interacting with each other so to constitute a complex
lattice, but ncRNAs could be involved also in the recognition for the sim-
plicity of a RNA-based bridge. They could also be involved together in the
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coupler. A selective releasing system for the mRNAs identied by the code
to be released is also necessary. Their specic lattice should be broken ,
in some way. (c) A triggered mRNA degrading system could be exactly
that already described in P-bodies. But how the system could recognize
the incoming mRNA as to be degraded? It could be that it bears a specic
tag, which could simply be for example 4E-T bound to eIF4E, while the
mRNAs already stored in P-bodies are not tagged, for some reason.
C.2 Decoding
The verication of CDS paralogy is simple, while that of 5'/3' UTR site
involvement rather complex. From the available data we can simply iso-
late those mRNAs which after EGF stimulation are translatome increased
when other mRNAs are transcriptome increased. The overlapping should
be minimal or absent, after having eliminated the highly expressed tran-
scription factors at the top of our list. The code is inside these genes. Let
us suppose that no matching between mRNAs associate in proteins families
and these two groups of mRNAs is present. We then need to test the sec-
ond hypothesis. We isolate the PFs of the 5' and 3' UTRs of these mRNAs
and we have to establish if there is a preferential matching between pat-
terns of PFs in the two datasets. We basically need to establish clusters of
transcriptome increased and translatome increased mRNAs based on these
matching patterns, and these clusters should be at that time ontologically
compatible. This nding could verify the hypothesis.
C.3 Mechanistic verication of fake reprogramming
We need say three examples of EGF-induced genes buered in the polysomes
but which elicit in our dataset the polysomal increase of ontologically com-
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patible mRNAs. We consider the three best clusters. We identify the
transcriptome increased mRNA with the higher degree of connections with
translatome increased mRNAs. We repeat the EGF experiment and mea-
sure these mRNAs in a more precise way, by real-time PCR, and in a say
4-time kinetic. We should see the fake reprogramming in a clearer way and
conrm it in these three selected cases, provided that one mRNA is su-
cient to trigger the P-body release of other mRNAs. Then, for one of these
cases, we stably transfect the complete cDNA of the gene (chosen with
sort 5' and 3' UTRs) in the same HeLa cells under a tetracycline-inducible
promoter, and we activate the expression of the gene in a controlled and
dose-response way. We look then at the other mRNAs in polysomes. We
then repeat the same experiments using a luc reporter construct with the
5'3' UTRs of the transcriptionally induced gene and a renilla reporter con-
struct with the 5'3' UTRs of one of the P-body released, polysomally ac-
tivated mRNAs. We make deletion mutants of these two 5'/3' UTR PFs
in order to identpfy the cis regions necessary for the supposed coupling.
Looking for the fake reprogramming machinery. If it exists, it should be in
the P-bodies. We need to look in the literature about all the demonstrated
components of P-bodies (are there enrichment protocols and already pub-
lished mass spec papers?) and use all the available interactome maps to
look for associations of RBPs (1a hypothesis). For the 1b hypothesis we
should identify instead bridging ncRNAs between our clusters of ontologi-
cally compatible genes derived from the translatome/transcriptome DEGs
comparison. Why fake reprogramming? Why a cell should being so compli-
cate in genetically determining phenotypic transitions? Why should a cell
discard transcriptome DEG programs which should already be eective,
without polysome overlapping and fake reprogramming in determining the
phenotype? Some hypotheses:
a The RNA world. Our cells come from a world without DNA, therefore
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translatome DEGs where possibly at the origin the only way to in-
struct phenotypic changes. The crystallization of genetic information
into genomes made of DNA allowed its ecient preservation, and could
have determined a sort of "triggering role" for transcription in tran-
sition states: if you need to change state, remind it to the polysome
through transcriptome DEGs which elicit the release from P-bodies of
the really active mRNAs.
b If we exclude a small number of "trojan mRNAs" (those which are very
strongly increased, which are not buered by the polysomes) - by the
way, there should be a veriable positive relationship between posi-
tive DEG degree and tendency to be coupled genes - which typically
in our case are transcription factors instructing the second wave of
the EGF program, the other increased mRNAs following the deliv-
ery to the nucleus of the signaling pathway could be not enough to
trigger the complex rst cell reaction. P-bodies become therefore a
sort of amplication/resonance system, working in such a way to get
a number of mRNAs saying something in input and to release a bigger
number of ontologically compatible mRNAs, already transcribed, for
translation. The only drawback of this mechanism is that the system
looses the original mRNAs, they only work as rst relay runners in
this sort of two-stage relay race. Possibly this happens because the
machinery doing this has degraded the original mRNAs in order to
release the ontologically compatible mRNAs.
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